Lanicor

Digoxin, the active ingredient in Lanicor, is a cardiac glycoside presented as an oral tablet for oral use. It is employed in the management of heart failure and certain cardiac arrhythmias, particularly in adult patients where rate control is required. The drug acts by enhancing myocardial contractility while modulating electrical conduction through the atrioventricular node.

GNH USA supplies Lanicor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Digoxin is used in cardiovascular conditions that benefit from increased contractility and slowed atrioventricular conduction. - Heart failure: improves cardiac output and reduces symptoms of congestion. - Atrial fibrillation: controls ventricular rate by decreasing AV nodal conduction. - Atrial flutter: assists in rate control when other therapies are unsuitable.

Adverse reactions to digoxin can vary in frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Fatigue: reduced energy levels. - Blurred vision: transient visual disturbances. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe bradycardia: markedly slowed heart rate. - Heart block: impaired electrical conduction. - Hyperkalemia: elevated serum potassium. - Visual halos: yellow‑green color perception. - Confusion: altered mental status.

When prescribing digoxin, clinicians should consider several safety measures. - Monitor serum digoxin levels: ensure therapeutic range is maintained. - Adjust dose in renal impairment: reduce dosage for decreased clearance. - Caution with electrolyte disturbances: correct hypokalemia or hypermagnesemia. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in pregnancy: limited data, assess risk‑benefit. - Store at room temperature: keep in original container, protect from moisture.

Digoxin interacts with several medications that can alter its plasma concentration or cardiac effects.

Major Interactions (Avoid): - Amiodarone: markedly increases digoxin levels. - Quinidine: raises digoxin concentration and risk of toxicity. - Verapamil: enhances digoxin effect on AV node.

Moderate Interactions (Monitor Closely): - Spironolactone: may increase digoxin levels. - Diuretics (especially thiazides): affect electrolyte balance influencing toxicity. - Erythromycin: can elevate digoxin concentrations modestly.